Bank of America
BLTE

Bank of America’s Belite Bio BLTE Stock Holding History

Bank of America’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Buy
124,783
+121,005
+3,203% +$18.5M ﹤0.01% 2513
2026
Q1 		$602K Buy
3,778
+1,926
+104% +$324K ﹤0.01% 4800
2025
Q4 		$296K Buy
1,852
+681
+58% +$80.7K ﹤0.01% 5159
2025
Q3 		$86.7K Buy
1,171
+257
+28% +$16.9K ﹤0.01% 6656
2025
Q2 		$52.7K Sell
914
-4,310
-83% -$263K ﹤0.01% 6793
2025
Q1 		$346K Sell
5,224
-13,118
-72% -$790K ﹤0.01% 5861
2024
Q4 		$1.16M Buy
18,342
+4,891
+36% +$322K ﹤0.01% 4905
2024
Q3 		$631K Buy
13,451
+13,349
+13,087% +$647K ﹤0.01% 5349
2024
Q2 		$4.66K Sell
102
-1,622
-94% -$70.2K ﹤0.01% 7021
2024
Q1 		$66.2K Sell
1,724
-482
-22% -$21.6K ﹤0.01% 6422
2023
Q4 		$101K Buy
2,206
+2,143
+3,402% +$82.4K ﹤0.01% 6373
2023
Q3 		$2.01K Buy
+63
New +$1.58K ﹤0.01% 7142

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America's BLTE Position: Q2 2026 in Review

Bank of America increased its Belite Bio (BLTE) stake by 3,203% in Q2 2026, buying an estimated $18.5M and bringing the position to 124,783 shares worth $19.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

Bank of America first reported a position in BLTE in Q3 2023 and has held it in 12 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Bank of America held 124,783 shares of Belite Bio worth $19.2M as of Q2 2026.
  • Bank of America bought 121,005 Belite Bio shares in Q2 2026, an estimated $18.5M.
  • Belite Bio made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2513 holding.
  • Bank of America first reported a position in Belite Bio in Q3 2023 and has held it in 12 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.